新辅助化疗不同化疗途径对巨块型宫颈癌的临床价值分析  

Clinical Value of Neoadjuvant Chemotherapy in the Treatment of Massive Cervical Cancer

作　　者：万江[1] 

机构地区：[1]吉林市中心医院妇产科,吉林吉林132011

出　　处：《中国继续医学教育》2017年第5期144-145,共2页China Continuing Medical Education

摘　　要：目的探讨在巨块型宫颈癌患者新辅助化疗中不同化疗途径的应用价值。方法选取82例需实施新辅助化疗的巨块型宫颈癌患者,随机分为动脉组和静脉组,分别给予经动脉和静脉化疗。对比化疗有效率、术后生存率情况。结果静脉组第1疗程有效率高于动脉组(P<0.05),且前者第2疗程有效率低于后者(P<0.05),总有效率差异无统计学意义(P>0.05);两组术后6个月、12个月、24个月生存率差异均无统计学意义(P>0.05)。结论在巨块型宫颈癌中患者中静脉和动脉新辅助化疗效果相近,均有较高的临床价值。Objective To explore the clinical value of different paths of neoadjuvant chemotherapy in the treatment of massive cervical cancer. Methods g2 cases of patients with massive cervical cancer under going to carry out neoadjuvant chemotherapy were enrolled, who were randomly divided into arterial group and venous group, which were respectively given arterial and venous neoadjuvant chemotherapy. The effective rates and postoperative survival rates were compared. Results The effective rate of the first course of treatment in the venous group was.significantly higher than that in the arterial group （P〈0.05）, and the effective rate of the second course was significantly lower than that in the arterial, group （P〈0.05）, and the difference in the total effective rates was no significant （P 〉 0.05）. The differences in the survival rates after 6 months, 12 months and 24 months between the two groups were no significant （P 〉 0.05）. Conclusion In the patients with massive cervical cancer, the effect of neoadjuvant chemotherapy of vein and artery is similar.

关 键 词：新辅助化疗 化疗途径 巨块型宫颈癌 临床价值 

分 类 号：R737[医药卫生—肿瘤]